Julie Smith - 27 Feb 2025 Form 4 Insider Report for EXELIXIS, INC. (EXEL)

Role
Director
Signature
/s/ Nina Ayer, Attorney in Fact
Issuer symbol
EXEL
Transactions as of
27 Feb 2025
Net transactions value
-$1,322,523
Form type
4
Filing time
28 Feb 2025, 20:35:48 UTC
Previous filing
15 Aug 2024
Next filing
30 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXEL Common Stock Options Exercise $638,924 +31,167 +289% $20.50 41,945 27 Feb 2025 Direct F1
transaction EXEL Common Stock Options Exercise $461,570 +23,347 +56% $19.77 65,292 27 Feb 2025 Direct F1
transaction EXEL Common Stock Sale $2,078,619 -54,514 -83% $38.13 10,778 27 Feb 2025 Direct F1, F2
transaction EXEL Common Stock Options Exercise $381,442 +19,294 +179% $19.77 30,072 28 Feb 2025 Direct F1
transaction EXEL Common Stock Sale $725,840 -19,294 -64% $37.62 10,778 28 Feb 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EXEL Option (right to buy) Options Exercise $0 -31,167 -100% $0.000000 0 27 Feb 2025 Common Stock 31,167 $20.50 Direct F3
transaction EXEL Option (right to buy) Options Exercise $0 -23,347 -55% $0.000000 19,294 27 Feb 2025 Common Stock 23,347 $19.77 Direct F4
transaction EXEL Option (right to buy) Options Exercise $0 -19,294 -100% $0.000000 0 28 Feb 2025 Common Stock 19,294 $19.77 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 10,015 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units ("RSUs"). Each RSU is the economic equivalent of one share of Common Stock.
F2 Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $37.75 to $38.37. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
F3 The option, representing the right to purchase a total of 31,167 shares of Common Stock, became fully exercisable on May 24, 2018.
F4 The option, representing the right to purchase a total of 42,641 shares of Common Stock, became fully exercisable on May 23, 2019.